CO6501157A2 - Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh - Google Patents
Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodhInfo
- Publication number
- CO6501157A2 CO6501157A2 CO11112331A CO11112331A CO6501157A2 CO 6501157 A2 CO6501157 A2 CO 6501157A2 CO 11112331 A CO11112331 A CO 11112331A CO 11112331 A CO11112331 A CO 11112331A CO 6501157 A2 CO6501157 A2 CO 6501157A2
- Authority
- CO
- Colombia
- Prior art keywords
- addition salts
- azabifenylaminobenzoic
- trometamine
- acid derivatives
- dhodh inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a nuevas sales de adición cristalinas de (i) trometamina con (ii) un derivado de ácido azabifenilaminobenzoico de fórmula (I)en la queR1 se selecciona del grupo que consiste en alquilo C1-C4, cicloalquilo C3-C6 y CF3, G1 se selecciona de átomos de nitrógeno y grupos CH, C(CH3) y C(CF3), yG2 representa un grupo fenilo opcionalmente sustituido con uno o dos sustituyentes seleccionados de cloro, fluoro, metoxi, etoxi, isopropoxi, trifluorometoxi, CF3, y CONR7R8, en donde R7 es hidrógeno y R8 es ciclopropilo o R7 y R8 junto con el átomo de nitrógeno al que están unidos forman un grupo de fórmulaDonde n es 1y sus solvatos farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09382032A EP2230232A1 (en) | 2009-03-13 | 2009-03-13 | Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as DHODH inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6501157A2 true CO6501157A2 (es) | 2012-08-15 |
Family
ID=40671396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11112331A CO6501157A2 (es) | 2009-03-13 | 2011-09-01 | Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh |
Country Status (21)
Country | Link |
---|---|
US (1) | US20120003183A1 (es) |
EP (2) | EP2230232A1 (es) |
JP (1) | JP2012520251A (es) |
KR (1) | KR20110126695A (es) |
CN (1) | CN102341372A (es) |
AR (1) | AR075737A1 (es) |
AU (1) | AU2010223527A1 (es) |
CA (1) | CA2754785A1 (es) |
CL (1) | CL2011002213A1 (es) |
CO (1) | CO6501157A2 (es) |
EA (1) | EA201101298A1 (es) |
EC (1) | ECSP11011384A (es) |
IL (1) | IL214517A0 (es) |
MX (1) | MX2011009147A (es) |
NZ (1) | NZ594491A (es) |
PE (1) | PE20120328A1 (es) |
SG (2) | SG173824A1 (es) |
TW (1) | TW201033177A (es) |
UY (1) | UY32465A (es) |
WO (1) | WO2010102825A1 (es) |
ZA (1) | ZA201105743B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
EP2135610A1 (en) * | 2008-06-20 | 2009-12-23 | Laboratorios Almirall, S.A. | Combination comprising DHODH inhibitors and methotrexate |
EP2239256A1 (en) | 2009-03-13 | 2010-10-13 | Almirall, S.A. | Sodium salt of 5-cyclopropyl-2-{[2-(2,6-difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as DHODH inhibitor |
EP2314577A1 (en) | 2009-10-16 | 2011-04-27 | Almirall, S.A. | Process for manufacturing 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid |
CN110903219A (zh) * | 2018-09-18 | 2020-03-24 | 广东东阳光药业有限公司 | 酰胺衍生物的盐及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9804343D0 (en) | 1998-02-27 | 1998-04-22 | Univ Cardiff | Chemical compounds |
ATE396719T1 (de) | 2001-04-05 | 2008-06-15 | Aventis Pharma Inc | Verwendung von (z)-2-cyano-3-hydroxy-but-2- ensäure-(4'-trifluoromethylphenyl)-amid zur behandlung der multiplen sklerose |
PE20030120A1 (es) * | 2001-06-19 | 2003-02-12 | Merck & Co Inc | Sal amina de un antagonista de receptor de integrin |
WO2003006424A1 (en) | 2001-07-10 | 2003-01-23 | 4Sc Ag | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
WO2004056747A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
CN1993125A (zh) | 2004-05-21 | 2007-07-04 | Uab研究基金会 | 涉及嘧啶合成抑制剂的组合物和方法 |
WO2006022442A1 (ja) | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | ジヒドロオロテートデヒドロゲナーゼ阻害活性を有する新規複素環アミド誘導体 |
MX2007004265A (es) | 2004-10-19 | 2008-03-04 | Aventis Pharma Inc | Uso de (4'trifluorometilfenil) -amida del acido (z) - 2 - ciano - 3 - hidroxi-but - 2- enoico para tratar la enfermedad inflamatoria del intestino. |
UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
-
2009
- 2009-03-13 EP EP09382032A patent/EP2230232A1/en not_active Withdrawn
-
2010
- 2010-02-24 UY UY0001032465A patent/UY32465A/es unknown
- 2010-03-08 TW TW099106618A patent/TW201033177A/zh unknown
- 2010-03-11 WO PCT/EP2010/001549 patent/WO2010102825A1/en active Application Filing
- 2010-03-11 EA EA201101298A patent/EA201101298A1/ru unknown
- 2010-03-11 PE PE2011001597A patent/PE20120328A1/es not_active Application Discontinuation
- 2010-03-11 MX MX2011009147A patent/MX2011009147A/es not_active Application Discontinuation
- 2010-03-11 AR ARP100100740A patent/AR075737A1/es not_active Application Discontinuation
- 2010-03-11 NZ NZ594491A patent/NZ594491A/xx not_active IP Right Cessation
- 2010-03-11 SG SG2011060829A patent/SG173824A1/en unknown
- 2010-03-11 CN CN2010800108779A patent/CN102341372A/zh active Pending
- 2010-03-11 AU AU2010223527A patent/AU2010223527A1/en not_active Abandoned
- 2010-03-11 SG SG10201400568PA patent/SG10201400568PA/en unknown
- 2010-03-11 CA CA2754785A patent/CA2754785A1/en not_active Abandoned
- 2010-03-11 US US13/256,104 patent/US20120003183A1/en not_active Abandoned
- 2010-03-11 JP JP2011553359A patent/JP2012520251A/ja active Pending
- 2010-03-11 KR KR1020117021320A patent/KR20110126695A/ko not_active Application Discontinuation
- 2010-03-11 EP EP10708733A patent/EP2406222A1/en not_active Withdrawn
-
2011
- 2011-08-04 ZA ZA2011/05743A patent/ZA201105743B/en unknown
- 2011-08-08 IL IL214517A patent/IL214517A0/en unknown
- 2011-09-01 CO CO11112331A patent/CO6501157A2/es active IP Right Grant
- 2011-09-08 CL CL2011002213A patent/CL2011002213A1/es unknown
- 2011-10-07 EC EC2011011384A patent/ECSP11011384A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR075737A1 (es) | 2011-04-20 |
SG173824A1 (en) | 2011-09-29 |
US20120003183A1 (en) | 2012-01-05 |
PE20120328A1 (es) | 2012-03-29 |
TW201033177A (en) | 2010-09-16 |
EP2406222A1 (en) | 2012-01-18 |
ZA201105743B (en) | 2012-04-25 |
UY32465A (es) | 2010-05-31 |
ECSP11011384A (es) | 2011-11-30 |
KR20110126695A (ko) | 2011-11-23 |
WO2010102825A1 (en) | 2010-09-16 |
CL2011002213A1 (es) | 2012-03-09 |
EA201101298A1 (ru) | 2012-04-30 |
MX2011009147A (es) | 2011-09-15 |
CN102341372A (zh) | 2012-02-01 |
CA2754785A1 (en) | 2010-09-16 |
NZ594491A (en) | 2013-11-29 |
SG10201400568PA (en) | 2014-07-30 |
EP2230232A1 (en) | 2010-09-22 |
IL214517A0 (en) | 2011-09-27 |
AU2010223527A1 (en) | 2011-08-25 |
JP2012520251A (ja) | 2012-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6501157A2 (es) | Sales de adición de trometamina con derivados de ácido azabifenilaminobenzoico como inhibidores de dhodh | |
ECSP12012212A (es) | Derivados de ariletinilo | |
ECSP11011365A (es) | Sales de adición de aminas que contienen grupos hidroxilo y/o carboxílicos con derivados de ácido aminonicotínico como inhibidores de dhodh | |
ES2669189T3 (es) | Compuestos de carbazol útiles como inhibidores del bromodominio | |
CY1117481T1 (el) | Φαρμακευτικη συνθεση που περιεχει παραγωγο κινολινης | |
CO6321276A2 (es) | Derivados de tiazol usados como inhibidores de pi3- cinasa | |
RS53830B1 (en) | INDASOLS SUBSTITUTED BY OXAZOLE AS PI3-KINASE INHIBITORS | |
AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
AR082112A1 (es) | Derivados de imidazopiridina, su procedimiento de preparacion y su aplicacion en terapeutica | |
AR081426A1 (es) | Derivados de pirazol inhibidores del receptor sigma | |
UY39338A (es) | Derivados de piperidinona como inhibidores mdm2, composiciones farmacéuticas que los contienen y sus usos | |
EA201170096A1 (ru) | Замещенные производные пиримидона | |
ECSP10010337A (es) | Derivados de carboxamidas azabicíclicas, su preparación y su aplicación en terapéutica | |
ECSP066829A (es) | 5,6 dialquil-7 -amino-triazolopirimidinas, procedimientos para su preparacion y el uso de las mismas para combatir hongos nocivos | |
ES2587284T3 (es) | 5-Fluoro-pirimidinas 2,4-disustituidas como inhibidores selectivos de CDK9 | |
AR083903A1 (es) | Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos | |
AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
AR072803A1 (es) | Tetrahidrocinolinas como inhibidores de la 11- beta -hsd1 para la diabetes | |
AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
ES2570659T3 (es) | Agonistas de adenosina A1 para el tratamiento del glaucoma y de la hipertensión ocular | |
BR112013017416A2 (pt) | derivado de indola ou indazola ou sal do mesmo | |
RS53965B1 (en) | ACILBENZENA DERIVATIVES | |
AR085542A1 (es) | Compuestos de azaespirodecanona como inhibidores de hsl | |
AR082973A1 (es) | Derivados de dihidrobenzoxatiazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
NI201100115A (es) | Derivados de morfina - 6 - glucuronido, su preparación y su aplicación en terapéutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted |